相似文献
1
Increased projection of MHC and tumor antigens in murine B16-BL6 melanoma induced by hydrostatic pressure and chemical crosslinking.
Cancer Immunol Immunother. 1993 May;36(5):293-9. doi: 10.1007/BF01741167.
2
Induction of cell-mediated immunity against B16-BL6 melanoma in mice vaccinated with cells modified by hydrostatic pressure and chemical crosslinking.
Cancer Immunol Immunother. 1993 May;36(5):300-6. doi: 10.1007/BF01741168.
3
Surface projection of murine major histocompatibility determinants induced by hydrostatic pressure and cytokines.
Pathobiology. 1996;64(3):142-9. doi: 10.1159/000164028.
4
MHC antigen expression by melanomas recovered from mice treated with allogeneic mouse fibroblasts genetically modified for interleukin-2 secretion and the expression of melanoma-associated antigens.
Cancer Immunol Immunother. 1994 Mar;38(3):185-93. doi: 10.1007/BF01525640.
5
6
Interferon-mediated enhancement of metastasis. Are MHC antigens involved?
Clin Exp Metastasis. 1987 Oct-Dec;5(4):277-87. doi: 10.1007/BF00120723.
7
In vivo H-2K and H-2D antigen expression in two allogeneic mouse tumours of low immunogenicity.
Immunol Cell Biol. 1987 Aug;65 ( Pt 4):323-8. doi: 10.1038/icb.1987.36.
8
Rejection of B16 melanoma induced by expression of a transfected major histocompatibility complex class I gene.
Mol Cell Biol. 1988 Apr;8(4):1857-61. doi: 10.1128/mcb.8.4.1857-1861.1988.
9
10
Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells.
Cancer Res. 2001 Feb 1;61(3):1095-9.
引用本文的文献
1
Induction of cell-mediated immunity against B16-BL6 melanoma in mice vaccinated with cells modified by hydrostatic pressure and chemical crosslinking.
Cancer Immunol Immunother. 1993 May;36(5):300-6. doi: 10.1007/BF01741168.
本文引用的文献
1
AN INHIBITOR OF VIRAL ACTIVITY APPEARING IN INFECTED CELL CULTURES.
Proc Natl Acad Sci U S A. 1959 Mar;45(3):385-9. doi: 10.1073/pnas.45.3.385.
2
Differential expression of H-2 gene products in tumour cells in associated with their metastatogenic properties.
Nature. 1980 Nov 13;288(5787):179-81. doi: 10.1038/288179a0.
3
Lack of expression of HLA antigens on choriocarcinoma cell lines.
Tissue Antigens. 1980 Aug;16(2):195-202. doi: 10.1111/j.1399-0039.1980.tb00603.x.
4
Active immunization of hamsters against pancreatic carcinoma with lipid-treated cells or their shed antigens.
Cancer Res. 1984 Mar;44(3):946-8.
5
Inhibition of growth and metastases in mice by immunization with cholesterol hemisuccinate-enriched tumor cells.
Cancer Lett. 1984 Dec;25(2):153-61. doi: 10.1016/s0304-3835(84)80040-3.
6
Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function.
Adv Cancer Res. 1984;42:1-65. doi: 10.1016/s0065-230x(08)60455-8.
7
Serologic cross-reactivity between Class I MHC molecules and an H-2-linked differentiation antigen as detected by monoclonal antibodies.
J Exp Med. 1984 Jan 1;159(1):21-40. doi: 10.1084/jem.159.1.21.
8
Induction of delayed hypersensitivity reactions in cancer patients by cholesterol-hemisuccinate-treated autologous tumor cells.
J Natl Cancer Inst. 1983 Mar;70(3):465-7.
9
Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation.
Nature. 1984;311(5988):750-2. doi: 10.1038/311750a0.
10
Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2.
Science. 1984 Sep 28;225(4669):1487-9. doi: 10.1126/science.6332379.
Zotero 插件